Biogen Inc (BIIB) is down 2.82% Wednesday In Premarket Trading

Wednesday, September 22, 2021 08:09 AM | InvestorsObserver Analysts

Mentioned in this article

Biogen Inc (BIIB) is down 2.82% Wednesday In Premarket Trading

Biogen Inc (BIIB) has fallen Wednesday morning, with the stock falling -2.82% in pre-market trading to 287.2. BIIB's short-term technical score of 43 indicates that the stock has traded less bullishly over the last month than 57% of stocks on the market. In the Drug Manufacturers - General industry, which ranks 128 out of 146 industries, BIIB ranks higher than 57% of stocks. Biogen Inc has fallen 13.52% over the past month, closing at $342.75 on August 25. During this period of time, the stock fell as low as $295.95 and as high as $347.74. BIIB has an average analyst recommendation of Buy. The company has an average price target of $406.89.

BIIB has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on BIIB!

See Full BIIB Report

Biogen Inc has a Long-Term Technical rank of 55. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 45% of the market scoring higher. In the Drug Manufacturers - General industry which is number 51 by this metric, BIIB ranks better than 33% of stocks.

Important Dates for Investors in BIIB:

-Biogen Inc is set to release earnings on 10/20/2021. During their last earnings release the company posted EPS of $12.69. -We do not have a set dividend date for Biogen Inc at this time. Click Here To Get The Full Report on Biogen Inc (BIIB)